基因工程T细胞和瘤透性淋巴细胞疗法
Heinz Läubli1,2,3, Andreas Holbro2,4,5
1Division of Haematology, University Hospital Basel, Basel, Switzerland.
Swiss medical weekly
|August 14, 2025
概括
创新的免疫疗法,包括CAR T细胞和瘤透性淋巴细胞疗法,利用患者的免疫系统对抗癌症. 这些个性化的治疗方法为血液瘤学患者提供了新的希望,这些患者患有特定的血液癌症.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 血液瘤学已经取得了重大进展.
- 免疫治疗方法正在彻底改变癌症治疗.
研究的目的:
- 审查CAR T细胞治疗和瘤透淋巴细胞治疗的原则.
- 突出其在个性化癌症治疗中的作用.
主要方法:
- 卡尔-T细胞疗法涉及对患者的T细胞进行基因改造.
- 瘤透淋巴细胞疗法隔离,扩大和重新注入患者的识别瘤抗原的T细胞.
主要成果:
- 卡尔-T细胞疗法在B细胞新生体 (B-ALL,淋巴瘤) 和多发性骨髓瘤中有效.
- 瘤透淋巴细胞疗法利用T细胞对瘤抗原的自然识别.
结论:
- 两种CAR T细胞和瘤透性淋巴细胞疗法都代表了个性化癌症护理的重大进展.
- 这些创新的治疗方法为血液瘤患者提供了新的治疗希望.
相关概念视频
01:27Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K